Josh Ismin presents at Mind the Gap Seminar - Randwick Health & Innovation Precinct (RHIP)

Hear from Josh Ismin, CEO and Co-Founder of Psylo, an Australian biotech company pioneering new treatments for mental health using psychedelics. This inspiring story makes us think about the relationship between technological innovation and the practice of medicine.

Previous
Previous

Psychedelic Science Newsletter - May 2023

Next
Next

Psylo Awarded o2h Kickstarter